Late-onset sepsis reduced in premature infants fed Prolacta’s 100% human milk-based fortifiers as part of an exclusive human milk diet
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis
Prolacta Bioscience reassures hospitals of the safety of its human milk-based nutritional products during the coronavirus pandemic
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Pasteurization Quality & Safety
New Analysis Published in the Journal Breastfeeding Medicine Finds Additional Clinically Significant Benefits From an Exclusive Human Milk Diet in the NICU
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Necrotizing Entercolitis (NEC) Product Total Parenteral Nutrition (TPN) Use
Length of Stay in the NICU and Association With Breastfeeding Rates | LATCH
Type: Blog
Topic(s): Clinical Studies Length of hospital stay
Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition
Type: Prolacta in the News
Topic(s): Clinical Studies Company Single Ventricle Congenital Heart Defects (SVP )
Prolacta Bioscience Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect
Type: Press Releases
Topic(s): Clinical Studies Single Ventricle Congenital Heart Defects (SVP )
New Journal of Perinatology Study Associates an Exclusive Human Milk Diet With Lower Total Hospital Costs for Very Low Birth Weight Infants
Type: Press Releases
Topic(s): Clinical Studies Cost Savings / Cost Effectiveness
Benefits of an Exclusive Human Milk Diet Extend Beyond Reduction of NEC, Finds New Study Published in the Journal Breastfeeding Medicine
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
Texas Children's Hospital Breast Milk Donor Program in the News!
Type: Prolacta in the News
Topic(s): Advocacy Clinical Studies Company
Not finding the reference you’re looking for?
Email us at info@prolacta.com
